Hefipime-Forte 2.25 Injection 1's belongs to the class of medications called ‘antibiotics’ used to treat bacterial infections. Bacterial infections are caused by the multiplication of harmful bacteria inside or on the body. These harmful bacteria produce chemicals known as toxins, which can damage tissue and make you sick. Symptoms of bacterial infection vary depending on the organ affected by bacteria.

Hefipime-Forte 2.25 Injection 1's is a combination of two medicines: Cefepime and Tazobactam. Cefepime is a cephalosporin antibiotic. It has bactericidal action (kills bacteria). It works by preventing the formation of the cell wall (the outer protective layer of bacteria, which is essential for its survival) by preventing protein synthesis. Tazobactam is a beta-lactamase inhibitor. It can improve the spectrum of antibacterial action by inhibiting the action of beta-lactamase. Beta-lactamase is an enzyme produced by bacteria that can destroy antibiotics (cefotaxime). Hefipime-Forte 2.25 Injection 1's is only used to treat bacterial infections and is not recommended for viral infections.

 Hefipime-Forte 2.25 Injection 1's will be administered by a healthcare professional; do not self-administer. The common side effects of Hefipime-Forte 2.25 Injection 1's are pain and swelling at the injection site and skin rash. These side effects are usually mild and temporary. However, if any of these side effects persist or get worse, inform your doctor immediately.

It is not recommended to take Hefipime-Forte 2.25 Injection 1's if you are allergic to penicillin, any cephalosporin antibiotic, or its contents. Before taking Hefipime-Forte 2.25 Injection 1's, inform your doctor if you have kidney problems, diabetes, gastrointestinal problems, especially colitis (inflammation of the large intestine), or use other antibiotics. Do not discontinue or abruptly stop using Hefipime-Forte 2.25 Injection 1's as it may lead to antibiotic resistance (bacteria become resistant to antibiotics). This medicine is not recommended in children aged less than two years. Hefipime-Forte 2.25 Injection 1's should be used with caution in pregnant women, breastfeeding mothers and elderly people. Hefipime-Forte 2.25 Injection 1's may interact with alcohol. Hefipime-Forte 2.25 Injection 1's may not affect your ability to drive.

Hefipime-Forte 2.25 Injection 1's contains Cefepime and Tazobactam. Cefepime is a cephalosporin antibiotic, whereas Tazobactam is a beta-lactamase inhibitor. Hefipime-Forte 2.25 Injection 1's has broad-spectrum activity and is effective against both gram-positive and gram-negative bacteria. It makes the drug effective in multiple moderate to severe bacterial infections such as urinary tract infections (UTI), skin infections, intra-abdominal infections, lower respiratory tract (lung) infections such pneumonia (inflammation of the air sacs present in lungs) and bronchitis (inflammation of the bronchi), septicemia (including infections of the bloodstream), and empiric treatment in febrile neutropenic patients (development of fever in patients with low neutrophil count).

Hefipime-Forte 2.25 Injection 1's should be used with caution in patients with kidney impairment. There is a risk of serious adverse events such as confusion, hallucinations, stupor (a state of near-unconsciousness), and seizures (fits). Hefipime-Forte 2.25 Injection 1's may cause Clostridium difficile-associated diarrhoea (CDAD), ranging from mild diarrhea to fatal colitis (inflammation of the large intestine). If CDAD is suspected or confirmed, the doctor may discontinue therapy and advise appropriate fluid and electrolyte management, protein supplementation, and antibiotic therapy to treat CDAD. A Hefipime-Forte 2.25 Injection 1's may cause positive direct Coomb’s test, which indicates antibodies against red blood cells. So, it is necessary to let your doctor know that you are taking this medicine before undergoing laboratory tests. Do not discontinue or abruptly stop the medication as it may lead to antibiotic resistance, a condition in which bacteria become resistant to antibiotics. Hefipime-Forte 2.25 Injection 1's may cause superinfection (additional infection caused by other microbes) on prolonged use.